UNSPSC 51385200: Nonsteroidal anti inflammatory quinazolines

Nonsteroidal anti inflammatory drugs made of benzopyrimidines, or compounds consisting of two six-membered rings, one benzene, one pyrimidine ring.

UNSPSC 51385200 Nonsteroidal anti-inflammatory quinazolines is a Class code that nominally covers a specific pharmaceutical compound class, but state and local procurement records show little activity aligned with this narrow therapeutic scope. The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, posted in June 2026 with a response deadline of July 26, 2023, which solicits naloxone (an opioid antagonist, not a nonsteroidal anti-inflammatory) and drug deactivation systems in support of community health initiatives. This mismatch between the code's pharmaceutical classification and the actual procurement suggests either a cataloging error in the state and local procurement database or that the code has been repurposed to tag emergency-response medical supplies outside its nominal product family.

The Seminole County opportunity targets annual quantities of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders must submit electronic proposals including unit costs, shipping, and delivery charges; comply with drug-free workplace and E-Verify requirements; and carry workers' compensation, commercial general liability, and professional liability insurance. The contract structure includes a two-year initial term with a one-year renewal option and a three-month probationary period. Potential FEMA funding introduces additional federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. Beyond this single record, the code shows no measurable recent state and local procurement activity, limiting visibility into issuing-body frequency, geographic concentration, or procurement trend.